Skip to main content

Diagnosis and Clinical Pictures

  • Chapter
  • First Online:
Surgery of the Adrenal Gland

Abstract

The discovery of incidental adrenal masses during imaging procedures has become progressively more frequent. In such situations a correct clinical and biochemical approach have to be performed in order to obtain information on the biological and functional nature of the adrenal mass. Clinicians are asked to establish whether the adrenal mass is an adenoma, a pheochromocytoma, an adrenal carcinoma or a metastasis, and to perform a correct laboratory evaluation to search for even mild derangements in adrenal secretion. Recognition of mild signs and symptoms related to slight adrenal hypersecretion may permit a precocious identification of diseases associated with significant morbidity and mortality. Indeed cardiovascular events represent the most frequent complications due to catecholamine release by a pheochromocytoma, or to chronic hypercortisolism as in Cushing’s syndrome. Finally, the early recognition of an adrenal carcinoma is of utmost importance to improve the outcome and the prognosis of this biologically aggressive tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lenders JWM, Eisenhofer G, Mannelli M et al (2005) Pheochromocytoma. Lancet 366:665–675

    Article  PubMed  Google Scholar 

  2. Pacak K, Eisenhofer G, Ahlman H et al (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metab 3:92–102

    Article  PubMed  Google Scholar 

  3. Eisenhofer G, Walther MM, Huynh TT et al (2001) Pheochromocytomas in von Hippel–Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab 86:1999–2008

    Article  CAS  PubMed  Google Scholar 

  4. Eisenhofer G, Lenders J, Linehan W et al (1999) Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel–Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 340:1872–1879

    Article  CAS  PubMed  Google Scholar 

  5. Eisenhofer G, Goldstein DS, Sullivan P et al (2005) Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 90:2068–2075

    Article  CAS  PubMed  Google Scholar 

  6. Bravo E (1994) Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 15:356–368

    CAS  PubMed  Google Scholar 

  7. Grossman A, Pacak K, Sawka A et al (2006) Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus? Ann N Y Acad Sci 1073:332–347

    Article  CAS  PubMed  Google Scholar 

  8. Mannelli M, Colagrande S, Valeri A et al (2010) Incidental and metastatic adrenal masses. Semin Oncol 37:649–661

    Article  CAS  PubMed  Google Scholar 

  9. Kaltsas G, Korbonits M, Heintz E et al (2001) Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 86:895–902

    Article  CAS  PubMed  Google Scholar 

  10. Shulkin BL, Thompson NW, Shapiro B et al (1999) Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-d-glucose PET. Radiology 212:35–41

    CAS  PubMed  Google Scholar 

  11. Hoegerle S, Nitzsche E, Altehoefer C et al (2002) Pheochromocytomas: detection with 18F DOPA whole body PET—initial results. Radiology 222:507–512

    Article  PubMed  Google Scholar 

  12. Trampal C, Engler H, Juhlin C et al (2004) Pheochromocytomas: detection with 11C hydroxyephedrine PET. Radiology 230:423–428

    Article  PubMed  Google Scholar 

  13. Pacak K, Eisenhofer G, Goldstein DS (2004) Functional imaging of endocrine tumors: role of positron emission tomography. Endocr Rev 25:568–580

    Article  PubMed  Google Scholar 

  14. Lindholm J, Juul S, Jørgensen JO et al (2001) Incidence and late prognosis of Cushing’s syndrome: a population-based study. J Clin Endocrinol Metab 86:117–123

    Article  CAS  PubMed  Google Scholar 

  15. Catargi B, Rigalleau V, Poussin A et al (2003) Occult Cushing’s syndrome in type-2 diabetes. J Clin Endocrinol Metab 88:5808–5813

    Article  CAS  PubMed  Google Scholar 

  16. Chiodini I, Mascia ML, Muscarella S et al (2007) Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Intern Med 147:541–548

    PubMed  Google Scholar 

  17. Pecori Giraldi F, Moro M, Cavagnini F (2003) Study group on the hypothalamo-pituitary-adrenal axis of the Italian Society of endocrinology gender-related differences in the presentation and course of Cushing’s disease. J Clin Endocrinol Metab 88:1554–1558

    Article  PubMed  Google Scholar 

  18. van Rossum EF, Lamberts SW (2004) Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res 59:333–357

    Article  PubMed  Google Scholar 

  19. Arnaldi G, Angeli A, Atkinson AB et al (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602

    Article  CAS  PubMed  Google Scholar 

  20. Mansmann G, Lau J, Balk E et al (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25:309–340

    Article  PubMed  Google Scholar 

  21. Vilar L, Freitas MC, Faria M et al (2007) Pitfalls in the diagnosis of Cushing’s syndrome. Arq Bras Endocrinol Metabol 51:1207–1216

    Article  PubMed  Google Scholar 

  22. Maurea S, Klain M, Mainolfi C et al (2001) The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses. J Nucl Med 42:884–892

    CAS  PubMed  Google Scholar 

  23. Mantero F, Terzolo M, Arnaldi G et al (2000) A survey on adrenal incidentaloma in Italy. Study Group on adrenal tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637–644

    Article  CAS  PubMed  Google Scholar 

  24. Terzolo M, Bovio S, Reimondo G (2009) Management of adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab 23:233–243

    Article  PubMed  Google Scholar 

  25. Barzon L, Sonino N, Fallo F et al (2003) Prevalence and natural history of adrenal incidentaloma. Eur J Endocrinol 149:273–285

    Article  CAS  PubMed  Google Scholar 

  26. Reincke M, Nieke J, Krestin GP et al (1992) Preclinical Cushing’s syndrome in adrenal “incidentalomas.” Comparison with adrenal Cushing’s syndrome. J Clin Endocrinol Metab 75:826–832

    Article  CAS  PubMed  Google Scholar 

  27. Russi S, Blumenthal HT, Gray SH (1945) Small adenomas of the adrenal cortex in hypertension and diabetes. Arch Intern Med 76:284–291

    Article  CAS  Google Scholar 

  28. Leibowitz G, Tsur A, Chayen SD et al (1996) Pre-clinical Cushing’s syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf) 44:717–722

    Article  CAS  Google Scholar 

  29. Osella G, Terzolo M, Reimondo G et al (1997) Serum markers of bone and collagen turnover in patients with Cushing’s syndrome and in subjects with adrenal incidentalomas. J Clin Endocrinol Metab 82:3303–3307

    Article  CAS  PubMed  Google Scholar 

  30. Sartorio A, Conti A, Ferrero S et al (1998) Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing’s syndrome and in patients with adrenal incidentaloma. Eur J Endocrinol 138:146–152

    Article  CAS  PubMed  Google Scholar 

  31. Terzolo M, Alì A, Osella G et al (1998) Subclinical Cushing’s syndrome in adrenal incidentaloma. Clin Endocrinol 48:89–97

    Article  CAS  Google Scholar 

  32. Bernini GP, Moretti A, Orlandini C et al (2005) Long-term morphological and hormonal follow up in a single unit on 115 patients with adrenal incidentaloma. Br J Cancer 92:1104–1109

    Article  CAS  PubMed  Google Scholar 

  33. Stowasser M (2009) Update in primary aldosteronism. J Clin Endocrinol Metab 94:3623–3630

    Article  CAS  PubMed  Google Scholar 

  34. Ganguly A (1998) Primary aldosteronism. N Eng J Med 339:1828–1834

    Article  CAS  Google Scholar 

  35. Gordon RD (1995) Primary aldosteronism. J Endocrinol Invest 18:495–511

    CAS  PubMed  Google Scholar 

  36. Bovio S, Cataldi A, Reimondo G et al (2006) Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 29:298–302

    CAS  PubMed  Google Scholar 

  37. Young WF Jr (2000) Management approaches to adrenal incidentalomas: a view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29:159–185

    Article  PubMed  Google Scholar 

  38. Kloos RT, Gross MD, Francis IR et al (1995) Incidentally discovered adrenal masses. Endocr Rev 16:460–484

    CAS  PubMed  Google Scholar 

  39. Kebebew E, Reiff E, Duh QY et al (2006) Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg 30:872–878

    Article  PubMed  Google Scholar 

  40. Golden SH, Robinson KA, Saldanha I et al (2009) Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 94:1853–1878

    Article  CAS  PubMed  Google Scholar 

  41. Wajchenberg BL, Albergaria Pereira PA, Medonca BB et al (2000) Adrenocortical carcinoma: clinical and laboratory observations. Cancer 88:711–736

    Article  CAS  PubMed  Google Scholar 

  42. Dackiw AP, Lee JE, Gagel RF et al (2001) Adrenal cortical carcinoma. World J Surg 25:914–926

    Google Scholar 

  43. Allolio B, Fassnacht M (2006) Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 91:2027–2037

    Article  CAS  PubMed  Google Scholar 

  44. Vassilopoulou-Sellin R, Schultz PN (2001) Adrenocortical carcinoma: clinical outcome at the end of the 20th century. Cancer 92:1113–1121

    Article  CAS  PubMed  Google Scholar 

  45. Fassnacht M, Libé R, Kroiss M, Allolio B (2011) Adrenocortical carcinoma: a clinician’s update. Nat Rev Endocrinol 7:323–335

    Article  CAS  PubMed  Google Scholar 

  46. Hahner S, Stuermer A, Kreissl M et al (2008) [123I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. J Clin Endocrinol Metab 93:2358–2365

    Article  CAS  PubMed  Google Scholar 

  47. Young WF (2007) The incidentally discovered adrenal mass. N Engl J Med 356:601–610

    Article  CAS  PubMed  Google Scholar 

  48. Terzolo M, Pia A, Alì A et al (2002) Adrenal incidentaloma: a new cause of the metabolic syndrome? Clin Endocrinol Metab 87:998–1003

    Article  CAS  Google Scholar 

  49. Korobkin M, Francis IR (1997) Imaging of adrenal masses. Urol Clin North Am 24:603–622

    Article  CAS  PubMed  Google Scholar 

  50. Turner HE, Moore NR, Byrne JV et al (1998) Pituitary, adrenal and thyroid incidentalomas. Endocr Relat Cancer 5:131–150

    Article  Google Scholar 

  51. Yun M, Kim W, Alnafisi N et al (2001) 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 42:1795–1799

    CAS  PubMed  Google Scholar 

  52. Arellano RS, Harisinghani MG, Gervais DA et al (2003) Image guided percutaneous biopsy of the adrenal gland: review of indications, technique, and complications. Curr Probl Diagn Radiol 32:3–10

    Article  PubMed  Google Scholar 

  53. Welch TJ, Sheedy PF II, Stephens DH et al (1994) Percutaneous adrenal biopsy: review of a 10-year experience. Radiology 193:341–344

    CAS  PubMed  Google Scholar 

  54. Lutz A, Stojkovic M, Schmidt M et al (2000) Adrenocortical function in patients with macrometastases of the adrenal gland. Eur J Endocrinol 143:91–97

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Gabriele Parenti or Massimo Mannelli .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Italia

About this chapter

Cite this chapter

Parenti, G., Mannelli, M. (2013). Diagnosis and Clinical Pictures. In: Valeri, A., Bergamini, C., Bellantone, R., Lombardi, C. (eds) Surgery of the Adrenal Gland. Springer, Milano. https://doi.org/10.1007/978-88-470-2586-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2586-8_4

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2585-1

  • Online ISBN: 978-88-470-2586-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics